Organic compounds

Details for Australian Patent Application No. 2007236115 (hide)

Owner Novartis AG

Inventors Sedrani, Richard; Fenton, Garry; Ostermann, Nils; Namoto, Kenji; Sirockin, Finton; Baeschlin, Daniel Kaspar

Agent Davies Collison Cave

Pub. Number AU-A-2007236115

PCT Pub. Number WO2007/115821

Priority 06122445.7 17.10.06 EP; 0607309.2 11.04.06 GB

Filing date 10 April 2007

Wipo publication date 18 October 2007

International Classifications

C07D 211/26 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 211/96 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/115821 Priority application(s): WO2007/115821

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007236116-Thienopyrimidines having MnKl /Mnk2 inhibiting activity for pharmaceutical compositions

2007236114-Chromen-2-one derivatives